1. Home
  2. AZTR vs JZXN Comparison

AZTR vs JZXN Comparison

Compare AZTR & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

N/A

Current Price

$0.19

Market Cap

1.9M

Sector

Health Care

ML Signal

N/A

JZXN

Jiuzi Holdings Inc.

N/A

Current Price

$1.37

Market Cap

2.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
AZTR
JZXN
Founded
2014
2019
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
2.0M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
AZTR
JZXN
Price
$0.19
$1.37
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
1.4M
6.8M
Earning Date
06-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
5.06
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.12
52 Week High
$1.40
$8.50

Technical Indicators

Market Signals
Indicator
AZTR
JZXN
Relative Strength Index (RSI) 46.04 49.73
Support Level $0.15 $0.86
Resistance Level $0.32 $2.00
Average True Range (ATR) 0.02 0.22
MACD 0.01 0.02
Stochastic Oscillator 76.76 72.83

Price Performance

Historical Comparison
AZTR
JZXN

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About JZXN Jiuzi Holdings Inc.

Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.

Share on Social Networks: